Overall rank by patents
#10,095
Across all tracked assignees
USPTO PatentsView assignee record - 31 granted patents across 12 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C30B (SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYS).
The verdict
Meishan holds 31 US patents across 12 technology areas, rank #10,095 of 50,000 tracked assignees.
Meishan BOYA Advanced Materials Co., Ltd. has been granted 31 US utility patents between 2020 and 2025, placing Meishan BOYA Advanced Materials Co., Ltd. at rank #10,095 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in C30B (SINGLE-CRYSTAL GROWTH ; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL ; PRODUCTION OF A HOMOGENEOUS POLYCRYS). As a Foreign Corporation, Meishan BOYA Advanced Materials Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Meishan sits between Mahle Engine Systems UK Ltd (31 patents, rank #10,091) and Mawetal Llc (31 patents, rank #10,099) - the closest US assignees by grant volume. The composite Innovation Score of 54.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 31 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Meishan BOYA Advanced Materials Co., Ltd.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Meishan BOYA Advanced Materials Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MAHLE ENGINE SYSTEMS UK LTD
31 patents
MANAGED PRESSURE OPERATIONS PTE. LTD
31 patents
MD HEALTHCARE INC.
31 patents
MEDTRUM TECHNOLOGIES INC.
31 patents
MERCK SERONO SA
31 patents
METABOLIC EXPLORER
31 patents
MICRODOSE THERAPEUTX, INC.
31 patents
Mawetal LLC
31 patents
MEISHAN BOYA ADVANCED MATERIALS CO., LTD.
31 patents
What this shows Meishan holds 31 patents at rank #10,095, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,095 in granted patent volume.
Other assignees with the most granted patents in Meishan's primary technology class.
Meishan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
55 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 3.2% |
| 2021 | 6 | 19.4% |
| 2022 | 5 | 16.1% |
| 2023 | 9 | 29.0% |
| 2024 | 7 | 22.6% |
| 2025 | 3 | 9.7% |
Top 12 of 12 technology areas
Overall rank by patents
#10,095
Across all tracked assignees
54.8 out of 100
How to use this portfolio
Meishan's 31 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.